These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 10467877

  • 1. [Immunology of tuberculosis: current status].
    Litvinov VI, Gergert VIa, Moroz AM, Apt AS, Eremeev VV, Kosmiadi GA, Kulikovskaia NV, Liadova IV, Nikoneko BV.
    Vestn Ross Akad Med Nauk; 1999; (7):8-11. PubMed ID: 10467877
    [Abstract] [Full Text] [Related]

  • 2. [Immunologic methods and their use for diagnosis in the treatment of pulmonary tuberculosis].
    Knoring BE.
    Probl Tuberk; 1994; (4):25-7. PubMed ID: 7984609
    [Abstract] [Full Text] [Related]

  • 3. Advances in diagnosis and therapy of childhood tuberculosis.
    Woods CR.
    Paediatr Respir Rev; 2006; 7 Suppl 1():S130-1. PubMed ID: 16798538
    [Abstract] [Full Text] [Related]

  • 4. [Differentiated approach to preventive treatment of new cases of tuberculosis in children].
    Mordovskaia LI, Aksenova VA, Gavril'ev SS, Ivanova AP.
    Probl Tuberk; 2001; (2):14-7. PubMed ID: 11490456
    [Abstract] [Full Text] [Related]

  • 5. New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil.
    Antas PR, Castello-Branco LR.
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):628-30. PubMed ID: 18440575
    [Abstract] [Full Text] [Related]

  • 6. [Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis].
    Lei JP, Xiong GL, Hu QF, Li Y, Zong PL, Tu SH, Tu RY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb; 42(2):86-9. PubMed ID: 18642658
    [Abstract] [Full Text] [Related]

  • 7. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA, Litvinov VI, Mambetov KB, Koshmuratov AG, Sabyrbekova TS.
    Probl Tuberk; 1998 Feb; (5):46-8. PubMed ID: 9866400
    [Abstract] [Full Text] [Related]

  • 8. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA, Kamenev VF, Kolomiets VM.
    Probl Tuberk Bolezn Legk; 2007 Feb; (9):30-3. PubMed ID: 18038603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tuberculosis: current state of knowledge: an epilogue.
    Leung CC, Lange C, Zhang Y.
    Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
    [Abstract] [Full Text] [Related]

  • 11. [The search for ways to improve the efficacy of tuberculosis revaccination in children with immunological deficiency].
    Chernushenko EF, Kadan LP, Kruglova IF, Podgainaia EA.
    Probl Tuberk; 1996 Oct; (1):29-32. PubMed ID: 8907482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI.
    Lik Sprava; 1994 Oct; (9-12):103-5. PubMed ID: 7604543
    [Abstract] [Full Text] [Related]

  • 14. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M, Shinjo K, Umemura M, Shigeno S, Harakuni T, Arakawa T, Matsuzaki G.
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [Abstract] [Full Text] [Related]

  • 15. DNA vaccines against tuberculosis.
    Lowrie DB.
    Curr Opin Mol Ther; 1999 Feb; 1(1):30-3. PubMed ID: 11249680
    [Abstract] [Full Text] [Related]

  • 16. BCG vaccination and interpretation of purified protein derivative test results.
    Li VW, Joe EK, Bowers K.
    Arch Dermatol; 1997 Jul; 133(7):916-7. PubMed ID: 9236537
    [No Abstract] [Full Text] [Related]

  • 17. Immunological research in tuberculosis: Memorandum from a WHO meeting.
    Bull World Health Organ; 1982 Jul; 60(5):723-7. PubMed ID: 6817934
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
    Romano M, Rindi L, Korf H, Bonanni D, Adnet PY, Jurion F, Garzelli C, Huygen K.
    Vaccine; 2008 Nov 11; 26(48):6053-63. PubMed ID: 18822333
    [Abstract] [Full Text] [Related]

  • 19. [BCG vaccination during changes in preventive strategies].
    Quast U.
    Fortschr Med; 1982 Mar 25; 100(12):524-9. PubMed ID: 7042499
    [No Abstract] [Full Text] [Related]

  • 20. [Immunology of tuberculosis and current status of vaccine development].
    Ulrichs T.
    Pneumologie; 2008 Mar 25; 62(3):143-7. PubMed ID: 18320494
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.